drugset / Trial / NCT00871273
Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of capecitabine in patients who have undergone a total gastrectomy.
Timeline
- Start
- 2009-11
- Primary completion
- 2013-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 625 mg/m2 | Oral |
| Subject | Capecitabine | Small molecule | 1250 mg/m2 | Oral |